Recommendations for management of diabetes during Ramadan: update 2015

Ibrahim M., Abu Al Magd M., Annabi F. A., Assaad-Khalil S., Ba-Essa E. M., Fahdil I., ...Daha Fazla

BMJ OPEN DIABETES RESEARCH & CARE, cilt.3, sa.1, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 3 Sayı: 1
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1136/bmjdrc-2015-000108
  • Dergi Adı: BMJ OPEN DIABETES RESEARCH & CARE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Emerging Sources Citation Index (ESCI), Scopus
  • İstanbul Üniversitesi Adresli: Evet

Özet

Since the first ADA working group report on the recommendations for management of diabetes during Ramadan in 2005 and our update in 2010, we received many inquiries asking for regular updates on information regarding education, nutritional habits and new oral and injectable agents that may be useful for the management of patients with diabetes during Ramadan. Patients can be stratified into their risk of hypoglycemia and/or complications prior to the start of the fasting period of Ramadan. Those at high risk of hypoglycemia and with multiple diabetic complications should be advised against prolonged fasting. Even in the lower hypoglycemia risk group, adverse effects may still occur. In order to minimize adverse side effects during fasting in patients with diabetes and improve or maintain glucose control, education and discussion of glucose monitoring and treatment regimens should occur several weeks prior to Ramadan. Agents such as metformin,